XHP intervention resulted in downregulation of these tumor suppressors (CCND2, PRKCG, CCN4) in tumor tissues and PC-3, DU145 cell lines, revealing XHP's regulatory role in the Wnt pathway. The gene discussed is CCN4; the disease is neoplasm.